Author:
Rigo Serena,Kyropoulou Myrto,Schoenenberger Cora-Ann,Palivan Cornelia G.
Publisher
Springer International Publishing
Reference95 articles.
1. Valles-Colomer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, Schiweck C, Kurilshikov A, Joossens M, Wijmenga C, Claes S, Van Oudenhove L, Zhernakova A, Vieira-Silva S, Raes J (2019) The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 4(4):623–632
2. Hill JM, Clement C, Pogue AI, Bhattacharjee S, Zhao YH, Lukiw WJ (2014) Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD). Front Aging Neurosci 6:127
3. Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du X, Zhang X, Yang D, Yang Y, Meng H, Li W, Melgiri ND, Licinio J, Wei H, Xie P (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry 21(6):786–796
4. Aminov RI (2010) A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol 1:134
5. Rigo S, Cai C, Gunkel-Grabole G, Maurizi L, Zhang X, Xu J, Palivan CG (2018) Nanoscience-based strategies to engineer antimicrobial surfaces. Adv Sci:1700892